SPHINX-31

N/A

Report date: 2023/12/22 11:25:50
NME

Base Information

Drug NameSPHINX-31
Drug Alias NameSPHINX-31Sphinx 31
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSRSF protein kinase 1 inhibitors
TargetsSRSF protein kinase 1
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesExonate Ltd
China Registration ClassN/A

Develop Information

Active CompaniesExonate Ltd
Inactive CompaniesN/A
Active IndicationsEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A